Avalo Therapeutics
AVTX
AVTX
36 hedge funds and large institutions have $88.3M invested in Avalo Therapeutics in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
–
Holders Change %
0%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
7
Increased
10
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$7.42M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$589K |
| 3 |
Millennium Management
New York
|
+$305K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$284K |
| 5 |
State Street
Boston,
Massachusetts
|
+$189K |
Top Sellers
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.48M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$605K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$413K |
| 4 |
AI
Atom Investors
Austin,
Texas
|
-$220K |
| 5 |
Renaissance Technologies
New York
|
-$181K |
